| abstract |
Described herein is (3,5-dibromo-4-hydroxyphenyl)(6-hydroxy-2-(1-hydroxyethyl)benzofuran-3-yl-4,5,7-d 3 )methanone, or a pharmaceutically acceptable salt or solvate thereof, and methods for treating or preventing gout or hyperuricemia comprising the administration of the compound. |